Drug intelligence / Profile preview

Ruanmaijian

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ruanmaijian is a Traditional Chinese Medicine (TCM) decoction developed by the Affiliated Longhua Hospital of Shanghai University of Traditional Chinese Medicine, specifically designed for the treatment of atherosclerosis and carotid plaque. The formula is rooted in the TCM principle of tonifying the kidney and resolving phlegm and stasis. It aims to reduce the progression of atherosclerotic lesions by regulating lipid metabolism, exerting anti-inflammatory effects, and stabilizing vulnerable plaques. Research suggests its mechanism involves the inhibition of the TLR4/MyD88/NF-κB signaling pathway and the promotion of autophagy in macrophages, thereby reducing foam cell formation and inflammatory cytokine release. It is primarily used as a hospital preparation for patients with carotid atherosclerosis and related cardiovascular conditions.

Other names
Ruanmai JianRuanmai Decoction
02

Targets

MYD88 (Myeloid differentiation primary response protein MyD88)NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Ruanmaijian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruanmaijian.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call